---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-027226"
form_type: "8-K"
ticker: null
cik: "0001840904"
company_name: "ATAI Life Sciences N.V."
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:20:34.745012+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# atai Life Sciences appoints two new independent directors; Camm departs board

## Summary
- Scott Braunstein, M.D. and Laurent Fischer, M.D. appointed as independent supervisory directors, subject to Dutch registration.
- Jason Camm stepped down after four years; resignation not due to any disagreement with the company.
- New directors bring pharma executive experience as atai advances to later-stage clinical trials.

## SEC filing metadata
- accession: 0001140361-24-027226
- form_type: 8-K
- cik: 0001840904
- company_name: ATAI Life Sciences N.V.
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840904/000114036124027226/0001140361-24-027226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840904/000114036124027226/ef20029704_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-027226
- JSON: https://secwatch.observer/filing/0001140361-24-027226.json
- Plain text: https://secwatch.observer/filing/0001140361-24-027226.txt

## Key facts
- Executive change
  Jason Camm resigned as supervisory director at ATAI Life Sciences N.V..
  - Action: resigned
  - Role: supervisory director
  source text: On May 19, 2024, Jason Camm resigned from his position as supervisory director of ATAI Life Sciences N.V. (the “Company” or “atai”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840904/000114036124027226/0001140361-24-027226-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.